Dernières nouvelles pour Celestica (NYSE:CLS) Stock

Celestica

Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.

Celestica Inc

Exchange Listed Funds Trust Cabana Target Leading Sector Aggressive ETF

Exchange Listed Funds Trust Cabana Target Leading Sector Conservative ETF

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical Inc

Trust for Professional Managers Convergence Long/Short Equity ETF

CLS HOLDINGS USA INC by CLS Holdings USA, Inc.

CLS Holdings USA Inc

Cleanspark Inc

ETC Cabana Target Leading Sector Moderate ETF

CANADIAN LIFE COS SPLT by CANADIAN LIFE COS SPLIT CORP.

Canadian Life Companies Split Corp

Catalyst Bancorp Inc

CHINA OIL & GAS GROUP LTD by China Oil & Gas Group, Ltd.

China Oil And Gas Group Ltd

UBS analyst David Vogt maintains Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Neutral and raises the price target from $101 to $208.

News

Price Target

Analyst Ratings

UBS Maintains Neutral on Celestica, Raises Price Target to $208

RBC Capital analyst Paul Treiber maintains Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Outperform and raises the price target from $185 to $225.

RBC Capital Maintains Outperform on Celestica, Raises Price Target to $225

Barclays analyst George Wang maintains Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Overweight and raises the price target from $146 to $220.

Barclays Maintains Overweight on Celestica, Raises Price Target to $220

Canaccord Genuity analyst Robert Young maintains Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Buy and raises the price target from $126 to $240.

Canaccord Genuity Maintains Buy on Celestica, Raises Price Target to $240

Celestica, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) shares are trading higher Tuesday after the company reported better-than-expected second quarter financial results, raised its fiscal-year 2025 guidance, and issued third quarter <a href="https://www.benzinga.com/node/46676131">guidance above estimates</a>.
What To Know: The company reported adjusted earnings per share of $1.39, beating the consensus estimate of $1.22. In addition, it reported sales of $2.89 billion, beating the consensus estimate of $2.65 billion and representing a 21% year-over-year increase. 
Celestica repurchased $40 million worth of shares in the quarter and reported its highest-ever adjusted operating margin of 7.4%.
Q3 Outlook: The company sees adjusted earnings per share from $1.37 to $1.53, versus the consensus estimate of $1.28. It also sees sales from $2.87 billion to $3.12 billion, versus the consensus estimate of $2.77 billion.
FY25 Outlook: Celestica expects adjusted earnings per share from $5.00 to $5.50, versus the consensus estimate of $5.02. It raised its sales guidance from $10.85 billion to $11.55 billion, versus the consensus estimate of $10.94 billion.
See Also: <a href="https://www.benzinga.com/markets/tech/25/07/46687078/booming-taiwan-chip-industry-faces-critical-worker-shortage">Booming Taiwan Chip Industry Faces Critical Worker Shortage</a>
CLS Price Action: At the time of publication, Celestica shares are trading 18.9% higher at $206.45, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Image via Shutterstock

Movers

Celestica Stock Is Moving Higher Tuesday: What's Going On?

U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday.
Shares of Sanmina Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANM#NASDAQ">SANM</a>) rose sharply during Tuesday's session after the company reported <a href="https://www.benzinga.com/quote/SANM/news">better-than-expected quarterly financial results.</a>
Sanmina reported quarterly earnings of $1.53 per share which beat the analyst consensus estimate of $1.42 per share. The company reported quarterly sales of $2.042 billion which beat the analyst consensus estimate of $1.983 billion.
Sanmina shares jumped 16.7% to $114.78 on Tuesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Sarepta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) shares jumped 25.3% to $17.37 after the U.S. Food and Drug Administration (FDA) recommended the removal of a voluntary hold for Elevidys.</li>
<li>Expro Group Holdings N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPRO#NYSE">XPRO</a>) gained 24.2% to $11.18 after the company reported better-than-expected second-quarter financial results and issued FY25 revenue guidance above estimates.</li>
<li>Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) rose 23% to $26.13 after the company reported better-than-expected second-quarter financial results and issued third-quarter sales guidance above estimates.</li>
<li>Polaris Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PII#NYSE">PII</a>) gained 21.7% to $60.26 after the company reported better-than-expected quarterly financial results.</li>
<li>Rich Sparkle Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANPA#NASDAQ">ANPA</a>) rose 21.7% to $31.69.</li>
<li>Celestica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) gained 16.7% to $202.41 after the company reported better-than-expected second-quarter financial results and raised its FY25 guidance.</li>
<li>Chart Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTLS#NYSE">GTLS</a>) gained 15.9% to $198.99 after the company reported better-than-expected second-quarter adjusted EPS results. Additionally, the company announced that its merger agreement with Flowserve has been terminated, and Baker Hughes will acquire all the outstanding stock of Chart Industries for $210 per share.</li>
<li>SoFi Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) rose 15.5% to $24.30 after the company raised FY25 EPS and sales guidance.</li>
<li>Commvault Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>) jumped 14.1% to $186.50 after the company reported better-than-expected first-quarter financial results and raised its FY26 sales guidance above estimates.</li>
<li>GeneDx Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) gained 13.5% to $96.37 after the company raised FY25 sales guidance above estimates.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) rose 11.3% to $71.48 after the company reported better-than-expected quarterly adjusted EPS and revenue results. Additionally, Susquehanna raised its price target on the stock from $70 to $75.</li>
<li>Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) gained 10% to $28.24 after the company reported better-than-expected quarterly financial results. Additionally, the company has announced a multi-year agreement with Indonesia&#8217;s Ministry of Health to expand image-guided therapy services to hospitals nationwide.</li>
<li>Simpson Manufacturing Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSD#NYSE">SSD</a>) rose 9.1% to $181.12 after the company reported second-quarter financial results and beat its EPS and revenue estimates.</li>
<li>TTM Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) gained 8.5% to $49.86.</li>
<li>CBRE Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBRE#NYSE">CBRE</a>) gained 8.2% to $158.64 after the company reported better-than-expected quarterly financial results and raised its FY25 adjusted EPS guidance above estimates.</li>
<li>Synopsys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) rose 8% to $639.84.</li>
<li>Incyte Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) rose 7.4% to $75.33 following second-quarter results.</li>
<li>Modine Manufacturing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOD#NYSE">MOD</a>) gained 7% to $112.91 after the company announced a $100 million data center business investment, where it will open a new Dallas facility and expand its Grenada site.</li>
<li>Crane Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) gained 5.1% to $199.69 after the company reported better-than-expected second-quarter financial results and raised its FY25 adjusted EPS guidance.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46679452/boeing-procter-gamble-and-3-stocks-to-watch-heading-into-tuesday">Boeing, Procter &amp; Gamble And 3 Stocks To Watch Heading Into Tuesday</a></li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

Trading Ideas

AMKR

ANPA

CBRE

CVLT

GTLS

INCY

RMBS

SANM

SNPS

SOFI

SRPT

TTMI

XPRO

Sanmina, Sarepta Therapeutics, Polaris, Celestica And Other Big Stocks Moving Higher On Tuesday

<h3>Gainers</h3>
<ul>
<li>ScanTech AI Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAI#NASDAQ">STAI</a>) stock moved upwards by 49.5% to $1.0 during Tuesday's pre-market session. The company's market cap stands at $13.8 million. </li>
<li>Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) shares moved upwards by 11.03% to $192.5. The company's market cap stands at $19.9 billion. As per the press release, Q2 earnings came out yesterday. </li>
<li>Nvni Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNI#NASDAQ">NVNI</a>) shares rose 8.8% to $0.75. The market value of their outstanding shares is at $63.4 million. </li>
<li>Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) shares rose 8.6% to $2.02. The market value of their outstanding shares is at $37.0 million. </li>
<li>Amkor Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) shares moved upwards by 7.86% to $22.9. The company's market cap stands at $5.2 billion. As per the press release, Q2 earnings came out yesterday. </li>
<li>Cadence Design Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) shares moved upwards by 7.11% to $357.5. The market value of their outstanding shares is at $91.5 billion. As per the press release, Q2 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Xperi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPER#NYSE">XPER</a>) shares fell 14.1% to $6.48 during Tuesday's pre-market session. The market value of their outstanding shares is at $343.2 million. </li>
<li>Harmonic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) stock decreased by 13.9% to $7.87. The company's market cap stands at $1.0 billion. As per the press release, Q2 earnings came out yesterday. </li>
<li>Mercurity Fintech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFH#NASDAQ">MFH</a>) shares fell 11.94% to $3.1. The company's market cap stands at $224.1 million. </li>
<li>3 E Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASK#NASDAQ">MASK</a>) stock decreased by 8.67% to $1.16. The market value of their outstanding shares is at $15.8 million. </li>
<li>Perfect (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PERF#NYSE">PERF</a>) stock declined by 8.17% to $2.25. The company's market cap stands at $249.5 million. As per the press release, Q2 earnings came out today. </li>
<li>Upland Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPLD#NASDAQ">UPLD</a>) shares fell 6.58% to $2.4. The market value of their outstanding shares is at $73.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CDNS

HLIT

INTZ

MASK

NVNI

PERF

STAI

UPLD

XPER

12 Information Technology Stocks Moving In Tuesday's Pre-Market Session

Shares of Celestica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results, raised its FY25 guidance, and issued third-quarter <a href="https://www.benzinga.com/markets/earnings/25/07/46676131/celestica-stock-surges-on-q2-earnings-beat-company-raises-2025-outlook-on-strengthening-demand">guidance above estimates</a>.
Celestica reported quarterly earnings of $1.39 per share which beat the analyst consensus estimate of $1.22 per share. The company reported quarterly sales of $2.893 billion which beat the analyst consensus estimate of $2.652 billion.
Celestica jumped 12.1% to $194.73 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>Salarius Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) shares gained 279.1% to $2.81 in pre-market trading. The company recently announced it has been granted an extension to meet Nasdaq&#8217;s equity and bid price standards.</li>
<li>Scinai Immunotherapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) rose 66.8% to $3.42 in pre-market trading.</li>
<li>ScanTech AI Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAI#NASDAQ">STAI</a>) climbed 39.3% to $0.9350 in pre-market trading after the company announced it entered into a non-binding letter of intent with Visiontec Systems for the planned purchase of additional Sentinel fixed gantry CT inspection systems.</li>
<li>Shineco, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SISI#NASDAQ">SISI</a>) shares jumped 38% to $0.21 in pre-market trading after falling 13% on Monday.</li>
<li>Sarepta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) gained 33.6% to $18.55 in pre-market trading following the U.S. Food and Drug Administration's (FDA) recommendation to lift the voluntary hold on Elevidys, Sarepta's gene therapy for Duchenne Muscular Dystrophy.</li>
<li>Fulcrum Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULC#NASDAQ">FULC</a>) surged 20.7% to $9.43 in pre-market trading after the company announced it will present topline results from the 12 mg dose cohort of its Phase 1b PIONEER trial.</li>
<li>Chart Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTLS#NYSE">GTLS</a>) surged 16.5% to $200.50 in pre-market trading.</li>
<li>Cellectis S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLLS#NASDAQ">CLLS</a>) gained 15.5% to $3.30 in pre-market trading. Cellectis will report its second quarter financial results on Aug. 4.</li>
<li>Donegal Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGICB#NASDAQ">DGICB</a>) rose 13.5% to $17.30 in pre-market trading after declining 3% on Monday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>AIM ImmunoTech Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIM#NYSE">AIM</a>) dipped 40.9% to $4.25 in pre-market trading. AIM ImmunoTech recently announced mid-year data from its Phase 2 DURIPANC trial.</li>
<li>Bakkt Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKKT#NYSE">BKKT</a>) declined 40% to $10.31 in pre-market trading after the company announced the pricing of $75 million public offering.</li>
<li>WANG &amp; LEE GROUP, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) dipped 37.5% to $0.0529 in pre-market trading. Wang &amp; Lee Group announced a 250-to-1 shares consolidation.</li>
<li>Profusa, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFSA#NASDAQ">PFSA</a>) shares tumbled 34.5% to $1.27 in pre-market trading after gaining 185% on Monday.</li>
<li>Ekso Bionics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) fell 27.3% to $3.27 in pre-market trading after the company announced second-quarter results.</li>
<li>Leslie&#8217;s, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) fell 27.1% to $0.47 in pre-market trading after the company announced preliminary third quarter fiscal financial results.</li>
<li>VisionWave Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VWAV#NASDAQ">VWAV</a>) declined 25.7% to $8.17 in pre-market trading. VisionWave Holdings shares jumped 368% on Monday after the company announced that it has secured $55 million in growth capital to scale its AI defense solutions.</li>
<li>Wag! Group Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) fell 19.7% to $0.0939 in pre-market trading. Wag! Group shares fell more than 6% on Monday after the company announced it has initiated Chapter 11 proceedings in a Delaware court.</li>
<li>Whirlpool Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHR#NYSE">WHR</a>) shares fell 16.3% to $81.93 in pre-market trading after the company reported worse-than-expected second-quarter financial results and cut its FY25 earnings guidance.</li>
<li>Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) fell 13.8% to $7.88 in pre-market trading after the company issued third-quarter guidance below estimates.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/07/46656981/wall-streets-most-accurate-analysts-give-their-take-on-3-utilities-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Utilities Delivering High-Dividend Yields</a></li>
</ul>
Photo via Shutterstock

Bakkt Holdings, Inc. Class A Common Stock

BKKT

CLLS

DGICB

EKSO

FULC

LESL

PFSA

SCNI

SISI

SLRX

VWAV

WLGS

Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

WIIM

Celestica shares are trading higher after the company reported better-than-expected Q2 financial results, raised its FY25 guidance, and issued Q3 guidance above estimates.

Celestica Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) reported financial results for the second quarter on Monday after the bell. Here&#8217;s a rundown of the <a href="https://www.benzinga.com/pressreleases/25/07/g46673477/celestica-announces-second-quarter-2025-financial-results">supply chain solutions company&#8217;s report</a>.
<ul class="wp-block-list">
<li>Q2 Revenue:&nbsp;$2.89 billion, versus&nbsp;<a href="http://benzinga.com/quote/CLS/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $2.65 billion</li>
<li>Q2 Adjusted EPS: $1.39, versus estimates of $1.22</li>
</ul>
Find out how CLS stock is currently doing: <a href="https://www.benzinga.com/quote/CLS" target="_blank" rel="noreferrer noopener">See the chart here.</a>
Total revenue was up 21% on a year-over-year basis, bolstered by &#8220;strong&#8221; adjusted operating margin.
Celestica said it repurchased 600,000 shares of its common stock for $40 million in the quarter. The company ended the period with $313.8 million in cash and cash equivalents.
&#8220;With our strong first half results, and a strengthening demand&nbsp;outlook&nbsp;from our CCS customers, we are increasing our full-year 2025&nbsp;outlook,&#8221; said Rob Mionis, president and CEO of Celestica.
Guidance:&nbsp;Celestica guided for third-quarter revenue of $2.88 billion to $3.13 billion versus estimates of $2.77 billion. The company expects third-quarter adjusted earnings to be in the range of $1.37 to $1.53 per share, versus&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;estimates of $1.28 per share.
Celestica also raised its full-year 2025 outlook. The company now expects 2025 revenue of $11.55 billion, up from prior guidance of $10.85 billion. Celestica sees adjusted earnings of $5.50 per share, up from prior guidance of $5 per share. According to <a href="http://pro.benzinga.com">Benzinga Pro</a> estimates, analysts are looking for revenue of $10.95 billion and earnings of $5.02 per share. 
CLS Price Action: <a href="http://benzinga.com/quote/cls" target="_blank" rel="noreferrer noopener">Celestica shares</a> were up 10.17% in after-hours Monday, trading at $191 at the time of publication, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/07/46674619/cadence-design-systems-beats-q2-earnings-estimates-raises-fy25-outlook-citing-broad-based-strength-ai-tailwinds">Cadence Design Systems Beats Q2 Earnings Estimates, Raises FY25 Outlook Citing &#8216;Broad-Based Strength,&#8217; AI Tailwinds</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/JHVEPhoto">JHVEPhoto</a>/Shutterstock.com

Earnings

Guidance

Global

After-Hours Center

Celestica Stock Surges On Q2 Earnings Beat, Company Raises 2025 Outlook On 'Strengthening' Demand

<h3>Gainers</h3>
<ul>
<li>ScanTech AI Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAI#NASDAQ">STAI</a>) shares increased by 54.0% to $1.03 during Monday's after-market session. The company's market cap stands at $13.2 million. </li>
<li>Nvni Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNI#NASDAQ">NVNI</a>) stock rose 21.01% to $0.83. The market value of their outstanding shares is at $38.7 million. </li>
<li>Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) stock increased by 10.73% to $191.98. The market value of their outstanding shares is at $19.5 billion. The company's, Q2 earnings came out today. </li>
<li>Cadence Design Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) shares rose 5.85% to $353.3. The market value of their outstanding shares is at $91.1 billion. The company's, Q2 earnings came out today. </li>
<li>Amkor Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) stock increased by 5.65% to $22.43. The market value of their outstanding shares is at $5.2 billion. As per the news, the Q2 earnings report came out today. </li>
<li>Rambus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares increased by 5.57% to $67.85. The company's market cap stands at $6.7 billion. As per the news, the Q2 earnings report came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Xperi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPER#NYSE">XPER</a>) shares declined by 13.8% to $6.5 during Monday's after-market session. The company's market cap stands at $343.2 million. </li>
<li>Harmonic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) stock decreased by 13.46% to $7.91. The company's market cap stands at $1.0 billion. The company's, Q2 earnings came out today. </li>
<li>Universal Security (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UUU#AMEX">UUU</a>) stock decreased by 9.69% to $3.07. The market value of their outstanding shares is at $8.0 million. As per the news, the Q4 earnings report came out today. </li>
<li>Upland Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPLD#NASDAQ">UPLD</a>) stock fell 8.18% to $2.36. The company's market cap stands at $54.9 million. </li>
<li>VeriSign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>) stock declined by 6.62% to $285.8. The company's market cap stands at $28.5 billion. The company's, Q2 earnings came out 2 days ago. </li>
<li>Mega Fortune Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGRT#NASDAQ">MGRT</a>) shares declined by 4.83% to $2.17. The company's market cap stands at $45.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MGRT

VRSN

12 Information Technology Stocks Moving In Monday's After-Market Session

Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) is looking for Q3 Adj EPS of $1.37-$1.53 vs $1.28 analyst estimate. sees sales of $2.875 billion-$3.125 billion vs $2.771 billion analyst estimate.

Celestica Sees Q3 Adj EPS $1.37-$1.53 vs $1.28 Est; Sees Sales $2.875B-$3.125B vs $2.771B Est

Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) raises FY2025 Adj EPS guidance from $5.00 to $5.50 vs $5.02 analyst estimate. Raises FY2025 sales outlook from $10.850 billion to $11.550 billion vs $10.945 billion estimate.

Celestica Raises FY2025 Adj EPS Guidance from $5.00 to $5.50 vs $5.02 Est; Raises FY2025 Sales Guidance from $10.850B to $11.550B vs $10.945B Est

Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) reported quarterly earnings of $1.39 per share which beat the analyst consensus estimate of $1.22 by 13.93 percent. This is a 52.75 percent increase over earnings of $0.91 per share from the same period last year. The company reported quarterly sales of $2.893 billion which beat the analyst consensus estimate of $2.652 billion by 9.09 percent. This is a 20.94 percent increase over sales of $2.392 billion the same period last year.

Earnings Beats

Celestica Q2 Adj. EPS $1.39 Beats $1.22 Estimate, Sales $2.893B Beat $2.652B Estimate

<h3>Companies Reporting Before The Bell</h3>
• Bank of Hawaii (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOH#NYSE">BOH</a>) is likely to report quarterly earnings at $1.05 per share on revenue of $174.39 million. 
• Business First Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFST#NASDAQ">BFST</a>) is likely to report quarterly earnings at $0.65 per share on revenue of $78.91 million. 
• Alliance Res Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARLP#NASDAQ">ARLP</a>) is projected to report quarterly earnings at $0.60 per share on revenue of $583.55 million. 
• Enterprise Prods Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPD#NYSE">EPD</a>) is expected to report quarterly earnings at $0.64 per share on revenue of $14.19 billion. 
• Rithm Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RITM#NYSE">RITM</a>) is estimated to report quarterly earnings at $0.52 per share on revenue of $1.17 billion. 
• New Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NGD#AMEX">NGD</a>) is estimated to report quarterly earnings at $0.10 per share on revenue of $319.96 million. 
• Alerus Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALRS#NASDAQ">ALRS</a>) is projected to report quarterly earnings at $0.55 per share on revenue of $69.95 million. 
• Revvity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVTY#NYSE">RVTY</a>) is estimated to report quarterly earnings at $1.14 per share on revenue of $711.31 million. 
• Bank of Marin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRC#NASDAQ">BMRC</a>) is expected to report quarterly earnings at $0.35 per share on revenue of $26.77 million. 
• Fomento Economico (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMX#NYSE">FMX</a>) is estimated to report quarterly earnings at $0.91 per share on revenue of $11.18 billion. 
• Provident Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROV#NASDAQ">PROV</a>) is projected to report quarterly earnings at $0.30 per share on revenue of $10.40 million. 
• Bankwell Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWFG#NASDAQ">BWFG</a>) is expected to report quarterly earnings at $0.85 per share on revenue of $24.31 million. 
<h3>Companies Reporting After The Bell</h3>
• Brixmor Property Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRX#NYSE">BRX</a>) is estimated to report quarterly earnings at $0.35 per share on revenue of $331.31 million. 
• Welltower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) is likely to report quarterly earnings at $0.49 per share on revenue of $2.49 billion. 
• TFI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFII#NYSE">TFII</a>) is projected to report quarterly earnings at $1.24 per share on revenue of $2.06 billion. 
• PotlatchDeltic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCH#NASDAQ">PCH</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $259.74 million. 
• NewtekOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEWT#NASDAQ">NEWT</a>) is estimated to report quarterly earnings at $0.51 per share on revenue of $74.22 million. 
• Bank of N.T Butterfield (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTB#NYSE">NTB</a>) is expected to report quarterly earnings at $1.19 per share on revenue of $144.84 million. 
• Exelixis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) is projected to report quarterly earnings at $0.61 per share on revenue of $577.73 million. 
• Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) is estimated to report quarterly earnings at $1.18 per share on revenue of $2.67 billion. 
• Cadence Design Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) is projected to report quarterly earnings at $1.42 per share on revenue of $1.25 billion. 
• Pathward Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASH#NASDAQ">CASH</a>) is projected to report quarterly earnings at $1.63 per share on revenue of $185.55 million. 
• Brown &amp; Brown (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) is estimated to report quarterly earnings at $0.99 per share on revenue of $1.28 billion. 
• Ameris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABCB#NYSE">ABCB</a>) is estimated to report quarterly earnings at $1.34 per share on revenue of $298.12 million. 
• Telefonica Brasil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIV#NYSE">VIV</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $2.59 billion. 
• Two Harbors Inv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWO#NYSE">TWO</a>) is expected to report quarterly earnings at $0.31 per share on revenue of $-23 million. 
• NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) is estimated to report quarterly earnings at $0.30 per share on revenue of $2.15 billion. 
• Kforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFRC#NYSE">KFRC</a>) is likely to report quarterly earnings at $0.60 per share on revenue of $334.05 million. 
• Firstsun Capital Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSUN#NASDAQ">FSUN</a>) is estimated to report quarterly earnings at $0.90 per share on revenue of $103.34 million. 
• Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) is expected to report quarterly earnings at $1.34 per share on revenue of $568.53 million. 
• Geovax Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) is likely to report quarterly loss at $0.41 per share on revenue of $479 thousand. 
• UFP Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFPI#NASDAQ">UFPI</a>) is estimated to report quarterly earnings at $1.89 per share on revenue of $1.85 billion. 
• Principal Financial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>) is expected to report quarterly earnings at $1.98 per share on revenue of $3.99 billion. 
• Nucor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) is projected to report quarterly earnings at $2.67 per share on revenue of $8.45 billion. 
• The Hartford Insurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>) is estimated to report quarterly earnings at $2.81 per share on revenue of $6.17 billion. 
• CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) is likely to report quarterly earnings at $0.85 per share on revenue of $966.16 million. 
• Cincinnati Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CINF#NASDAQ">CINF</a>) is estimated to report quarterly earnings at $1.39 per share on revenue of $2.79 billion. 
• Northeast Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBN#NASDAQ">NBN</a>) is expected to report quarterly earnings at $2.57 per share on revenue of $56.06 million. 
• Western Union (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WU#NYSE">WU</a>) is expected to report quarterly earnings at $0.44 per share on revenue of $1.04 billion. 
• Waste Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) is expected to report quarterly earnings at $1.89 per share on revenue of $6.35 billion. 
• Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) is projected to report quarterly earnings at $4.90 per share on revenue of $4.23 billion. 
• Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) is likely to report quarterly loss at $0.01 per share on revenue of $235.99 million. 
• Simpson Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSD#NYSE">SSD</a>) is expected to report quarterly earnings at $2.31 per share on revenue of $599.39 million. 
• Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) is projected to report quarterly earnings at $0.02 per share on revenue of $1.66 billion. 
• NBT Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBTB#NASDAQ">NBTB</a>) is projected to report quarterly earnings at $0.82 per share on revenue of $170.78 million. 
• Kilroy Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRC#NYSE">KRC</a>) is likely to report quarterly earnings at $0.59 per share on revenue of $269.64 million. 
• H2O America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTO#NASDAQ">HTO</a>) is likely to report quarterly earnings at $0.71 per share on revenue of $185.70 million. 
• COPT Defense Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDP#NYSE">CDP</a>) is expected to report quarterly earnings at $0.46 per share on revenue of $184.31 million. 
• Amkor Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) is projected to report quarterly earnings at $0.16 per share on revenue of $1.42 billion. 
• Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) is likely to report quarterly earnings at $1.63 per share on revenue of $889.41 million. 
• Whirlpool (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHR#NYSE">WHR</a>) is likely to report quarterly earnings at $1.66 per share on revenue of $3.84 billion. 
• Veralto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLTO#NYSE">VLTO</a>) is projected to report quarterly earnings at $0.89 per share on revenue of $1.34 billion. 
• Sanmina (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANM#NASDAQ">SANM</a>) is likely to report quarterly earnings at $1.31 per share on revenue of $1.98 billion. 
• Ekso Bionics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) is projected to report quarterly loss at $1.20 per share on revenue of $4.44 million. 
• GBank Financial Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBFH#NASDAQ">GBFH</a>) is likely to report quarterly earnings at $0.38 per share on revenue of $19.00 million. 
• Ranger Energy Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNGR#NYSE">RNGR</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $140.00 million. 
• Harmonic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) is estimated to report quarterly earnings at $0.01 per share on revenue of $133.02 million. 
• Curbline Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURB#NYSE">CURB</a>) is estimated to report quarterly earnings at $0.16 per share on revenue of $37.95 million. 
• Ultra Clean Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) is projected to report quarterly earnings at $0.24 per share on revenue of $501.10 million. 
• Seven Hills Realty Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEVN#NASDAQ">SEVN</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $7.87 million. 
• Rambus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) is estimated to report quarterly earnings at $0.50 per share on revenue of $166.98 million. 
• Piedmont Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PDM#NYSE">PDM</a>) is projected to report quarterly earnings at $0.35 per share on revenue of $141.91 million. 
• Merchants Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIN#NASDAQ">MBIN</a>) is expected to report quarterly earnings at $1.10 per share on revenue of $160.32 million. 
• Enterprise Finl Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EFSC#NASDAQ">EFSC</a>) is projected to report quarterly earnings at $1.20 per share on revenue of $164.87 million. 
• Beyond (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYON#NYSE">BYON</a>) is expected to report quarterly loss at $0.36 per share on revenue of $254.77 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABCB

ALRS

ARLP

BFST

BMRC

BWFG

BYON

CASH

CINF

CURB

EFSC

EXEL

Fomento Economico Mexicano S.A.B. De C.V.

FSUN

GBFH

GOVX

KFRC

MBIN

NBTB

NEWT

PROV

RITM

RNGR

RVTY

SEVN

TFII

TLRY

UCTT

UFPI

VLTO

WELL

Earnings Scheduled For July 28, 2025

Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) will release its quarterly earnings report on Monday, 2025-07-28. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Celestica to report an earnings per share (EPS) of $1.17.
Celestica bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Overview of Past Earnings</h3>
In the previous earnings release, the company beat EPS by $0.08, leading to a 3.35% drop in the share price the following trading session.
Here's a look at Celestica's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.12</td>
<td>1.06</td>
<td>0.93</td>
<td>0.81</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.20</td>
<td>1.11</td>
<td>1.04</td>
<td>0.91</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-3.0%</td>
<td>14.000000000000002%</td>
<td>18.0%</td>
<td>-4.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753452143_0.png" alt="eps graph" />
<h3>Celestica Share Price Analysis</h3>
Shares of Celestica were trading at $163.98 as of July 24. Over the last 52-week period, shares are up 232.24%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analysts' Take on Celestica</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Celestica.
A total of 9 analyst ratings have been received for Celestica, with the consensus rating being Outperform. The average one-year price target stands at $135.22, suggesting a potential 17.54% downside.
<h3>Comparing Ratings with Competitors</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Flex, Jabil and Fabrinet, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Flex, with an average 1-year price target of $53.67, suggesting a potential 67.27% downside.</li>
<li>Analysts currently favor an Buy trajectory for Jabil, with an average 1-year price target of $218.33, suggesting a potential 33.14% upside.</li>
<li>Analysts currently favor an Buy trajectory for Fabrinet, with an average 1-year price target of $267.83, suggesting a potential 63.33% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
In the peer analysis summary, key metrics for Flex, Jabil and Fabrinet are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Celestica</td>
<td>Outperform</td>
<td>19.91%</td>
<td>$273.90M</td>
<td>4.99%</td>
</tr>
<tr>
<td>Flex</td>
<td>Outperform</td>
<td>3.71%</td>
<td>$563M</td>
<td>4.44%</td>
</tr>
<tr>
<td>Jabil</td>
<td>Buy</td>
<td>15.71%</td>
<td>$681M</td>
<td>16.80%</td>
</tr>
<tr>
<td>Fabrinet</td>
<td>Buy</td>
<td>19.17%</td>
<td>$102.18M</td>
<td>4.34%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Celestica ranks at the bottom for Revenue Growth and Gross Profit, with the lowest values among peers. However, it has the highest Return on Equity, outperforming all others. Overall, Celestica's performance is mixed compared to its peers.
<h3>About Celestica</h3>
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity &amp; Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity &amp; Cloud Solutions segment.
<h3>Financial Insights: Celestica</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Celestica's remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 19.91%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Celestica's net margin is impressive, surpassing industry averages. With a net margin of 3.25%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Celestica's ROE stands out, surpassing industry averages. With an impressive ROE of 4.99%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Celestica's ROA excels beyond industry benchmarks, reaching 1.46%. This signifies efficient management of assets and strong financial health.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.6, caution is advised due to increased financial risk.
<a href="https://www.benzinga.com/quote/CLS/earnings">To track all earnings releases for Celestica visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What's Next: Celestica's Earnings Preview

Deep-pocketed investors have adopted a bearish approach towards Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CLS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 17 extraordinary options activities for Celestica. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 41% leaning bullish and 52% bearish. Among these notable options, 10 are puts, totaling $624,758, and 7 are calls, amounting to $322,060.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $140.0 to $185.0 for Celestica over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Celestica's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Celestica's whale trades within a strike price range from $140.0 to $185.0 in the last 30 days. 
<h3>Celestica 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753376457_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CLS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/01/25</td>
<td>$8.3</td>
<td>$7.8</td>
<td>$8.1</td>
<td>$160.00</td>
<td>$166.0K</td>
<td align="right">242</td>
<td align="right">206</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$33.5</td>
<td>$32.8</td>
<td>$33.5</td>
<td>$160.00</td>
<td>$100.5K</td>
<td align="right">204</td>
<td align="right">39</td>
</tr>
<tr>
<td>CLS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/01/25</td>
<td>$8.3</td>
<td>$7.8</td>
<td>$8.1</td>
<td>$160.00</td>
<td>$89.9K</td>
<td align="right">242</td>
<td align="right">317</td>
</tr>
<tr>
<td>CLS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$20.5</td>
<td>$20.4</td>
<td>$20.5</td>
<td>$155.00</td>
<td>$88.1K</td>
<td align="right">9</td>
<td align="right">44</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/25/25</td>
<td>$4.4</td>
<td>$4.1</td>
<td>$4.4</td>
<td>$165.00</td>
<td>$72.1K</td>
<td align="right">159</td>
<td align="right">174</td>
</tr>
</tbody>
</table>

<h3>About Celestica</h3>
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity &amp; Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity &amp; Cloud Solutions segment.
After a thorough review of the options trading surrounding Celestica, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Celestica</h3>
<ul>
<li>Trading volume stands at 2,376,075, with CLS's price up by 2.33%, positioned at $172.72.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 4 days.</li>
</ul>
<h3>What The Experts Say On Celestica</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $171.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Celestica, which currently sits at a price target of $170. 
&#x2A; An analyst from Citigroup has revised its rating downward to Neutral, adjusting the price target to $172. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Celestica, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Market Whales and Their Recent Bets on CLS Options

9 analysts have expressed a variety of opinions on Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $135.22, a high estimate of $172.00, and a low estimate of $115.00. This current average reflects an increase of 4.92% from the previous average price target of $128.88. 
<img src="https://www.benzinga.com/files/images/story/2025/1753124472_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Celestica among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$172.00</td>
<td>-</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$170.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>George Wang</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$146.00</td>
<td>$126.00</td>
</tr>
<tr>
<td>Thanos Moschopoulos</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$130.00</td>
<td>$118.00</td>
</tr>
<tr>
<td>Kevin Heal</td>
<td>Argus Research</td>
<td>Lowers</td>
<td>Buy</td>
<td>$120.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Thanos Moschopoulos</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$118.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Paul Treiber</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$120.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$115.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>George Wang</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$126.00</td>
<td>$157.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Celestica. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Celestica compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Celestica's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Celestica's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CLS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Celestica analyst ratings.</a>
<h2>Unveiling the Story Behind Celestica</h2>
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity &amp; Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity &amp; Cloud Solutions segment.
<h3>Breaking Down Celestica's Financial Performance</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Celestica's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 19.91%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Celestica's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 3.25%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Celestica's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.99%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Celestica's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.46%, the company showcases efficient use of assets and strong financial health.
Debt Management: Celestica's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.6, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>Analyst Ratings: Simplified</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Celestica: 9 Analysts Share Their Views

Citigroup analyst Atif Malik initiates coverage on Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Neutral rating and announces Price Target of $172.

Initiation

Citigroup Initiates Coverage On Celestica with Neutral Rating, Announces Price Target of $172

Press Releases

General

Celestica Recognized as One of Canada's Top Employers for Young People for the Second Consecutive Year

Celestica Announces Fourth Quarter and FY 2024 Financial Results

Celestica Announces 2025 Annual and Special Meeting of Shareholders

Celestica Q1 2025 Financial Results and Conference Call Friday, April 25, 2025

Celestica Announces First Quarter 2025 Financial Results

Celestica Announces Election of Directors and Approval of Equity Plan and Advanced Notice By-Law

Celestica Introduces Its Latest Enterprise Campus Switch, the ES1500, Designed for Performance and Reliability at the AI-Edge

Comments

Celestica

Actualités

Dernières nouvelles pour Celestica (NYSE:CLS) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL